Evidence map›Paper›PMID 37958912›Full record

ReviewInternational journal of molecular sciences2023

Natural Chalcones for the Management of Obesity Disease.

Maria Maisto, Adua Marzocchi, Niloufar Keivani, Vincenzo Piccolo, Vincenzo Summa, Gian Carlo Tenore

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Maria MaistoDepartment of Pharmacy, University of Naples Federico II, Via Domenico Montesano, 59, 80131 Naples, Italy.ORCID 0000-0002-0340-2254
Adua MarzocchiDepartment of Pharmacy, University of Naples Federico II, Via Domenico Montesano, 59, 80131 Naples, Italy.
Niloufar KeivaniDepartment of Pharmacy, University of Naples Federico II, Via Domenico Montesano, 59, 80131 Naples, Italy.
Vincenzo PiccoloDepartment of Pharmacy, University of Naples Federico II, Via Domenico Montesano, 59, 80131 Naples, Italy.ORCID 0000-0003-4480-5022
Vincenzo SummaDepartment of Pharmacy, University of Naples Federico II, Via Domenico Montesano, 59, 80131 Naples, Italy.ORCID 0000-0002-6288-2681
Gian Carlo TenoreDepartment of Pharmacy, University of Naples Federico II, Via Domenico Montesano, 59, 80131 Naples, Italy.ORCID 0000-0002-0251-9936
University of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last decade, the incidence of obesity has increased dramatically worldwide, reaching a dangerous pandemic spread. This condition has serious public health implications as it significantly increases the risk of chronic diseases such as type 2 diabetes, fatty liver, hypertension, heart attack, and stroke. The treatment of obesity is therefore the greatest health challenge of our time. Conventional therapeutic treatment of obesity is based on the use of various synthetic molecules belonging to the class of appetite suppressants, lipase inhibitors, hormones, metabolic regulators, and inhibitors of intestinal peptide receptors. The long-term use of these molecules is generally limited by various side effects and tolerance. For this reason, the search for natural alternatives to treat obesity is a current research goal. This review therefore examined the anti-obesity potential of natural chalcones based on available evidence from in vitro and animal studies. In particular, the results of the main in vitro studies describing the principal molecular therapeutic targets and the mechanism of action of the different chalcones investigated were described. In addition, the results of the most relevant animal studies were reported. Undoubtedly, future clinical studies are urgently needed to confirm and validate the potential of natural chalcones in the clinical prophylaxis of obesity.

Indexed as

Appetite DepressantsChalconesDiabetes Mellitus, Type 2AnimalsObesityAppetite DepressantsChalconesadipocyte differentiationanti-obesitybrowning processlipid accumulationnatural chalcones

Identifiers

PMID37958912
PMCPMC10648025
OpenAlexW4388303344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.